"10.1371_journal.pone.0120290","plos one","2015-03-17T00:00:00Z","Jukka Jokinen; Hanna Rinta-Kokko; Lotta Siira; Arto A Palmu; Mikko J Virtanen; Hanna Nohynek; Anni Virolainen-Julkunen; Maija Toropainen; J Pekka Nuorti","Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland; Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Helsinki, Finland; Department for Promotion of Welfare and Health, Ministry for Social Affairs and Health, Helsinki, Finland; Department of Epidemiology, School of Health Sciences, University of Tampere, Tampere, Finland","Conceived and designed the experiments: JJ. Analyzed the data: HRK. Contributed reagents/materials/analysis tools: LS MT AVJ. Wrote the paper: JJ HRK LS AAP MJV HN AVJ MT JPN.","The authors are or have been employees of the National Institute for Health and Welfare, which has received research funding from GlaxoSmithKline for a Nationwide effectiveness trial of the ten-valent pneumococcal conjugate vaccine. JJ, HRK, LS, AAP and MT are co-investigators in the trial; AAP has had travel paid for and honoraria by GlaxoSmithKline and Merck to attend expert group meetings; MJV has no competing interests; AVJ no competing interests; HN has no competing interests; JPN has no competing interests. These potential conflicts of interests do not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","03","Jukka Jokinen","JJ",9,FALSE,1,NA,1,9,TRUE,FALSE,FALSE,0,NA,FALSE
